|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
N01CO800001-038
|
$221,493,424
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-09
|
$26,766,352
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-09
|
$5,780,843
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA021765-33
|
$5,674,815
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
North Central Cancer Treatment Group
|
5U10CA025224-32
|
$5,018,658
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,547,976
|
Fine, Howard
|
CCR (NCI)
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
5U54CA151880-02
|
$2,329,637
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Pediatric Brain Tumor Consortium (PBTC)
|
5U01CA081457-13
|
$2,220,171
|
BOYETT, JAMES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-10
|
$1,464,654
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,420,622
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-09S3
|
$1,375,035
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
North Central Cancer Treatment Group
|
3U10CA025224-32S1
|
$1,347,651
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
Cancer Therapy & Research Center at UTHSCSA
|
5P30CA054174-19
|
$1,300,530
|
Thompson, Ian
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIA SC 004002
|
$1,295,164
|
Waldmann, Thomas
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,227,708
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,104,407
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other Ge
|
ZIA BC 010801
|
$976,696
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$881,476
|
Khan, Javed
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$828,305
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Determining the Fate of Transmembrane Proteins
|
ZIA BC 009392
|
$733,412
|
Weissman, Allan
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$651,131
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$644,844
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$552,204
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$548,663
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$489,703
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$489,703
|
Daar, Ira
|
CCR (NCI)
|
|
Pediatric Clinical Oncology Research Training Program
|
5K12CA090433-10
|
$475,607
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Protein Structure, Stability, and Amyloid Formation
|
ZIA BC 010440
|
$475,236
|
Nussinov, Ruth
|
CCR (NCI)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$469,166
|
Thiele, Carol
|
CCR (NCI)
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$469,166
|
Thiele, Carol
|
CCR (NCI)
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-28
|
$450,001
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Analyses of the Molecular Functions for D-Cyclins
|
5R01CA108420-08
|
$448,113
|
SICINSKI, PIOTR
|
DANA-FARBER CANCER INSTITUTE
|
|
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
|
4R01CA129182-03
|
$439,902
|
Jackson, Andrew
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$420,341
|
Kleiner, David
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$388,254
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$388,254
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Regulation of the mTOR Pathway By Nutrients
|
5R01CA103866-08
|
$378,696
|
SABATINI, DAVID
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
Sulfatide-reactive type II NKT cells: repertoire and function
|
5R01CA100660-07
|
$349,565
|
Kumar, Vipin
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
Pediatric Cancer, Family Conflict and Child Adjustment
|
5R01CA134794-02
|
$341,099
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
|
FEN-1 and PCNA Complexes and Human Genome Stability
|
5R01CA081967-12
|
$340,683
|
TAINER, JOHN
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Riluzole Prodrugs for Melanoma and ALS
|
1R43CA156781-01
|
$336,255
|
Reitz, Allen
|
FOX CHASE CHEMICAL DIVERSITY CENTER, INC
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIA BC 010015
|
$328,101
|
Wang, Ji Ming
|
CCR (NCI)
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIA BC 010806
|
$322,491
|
Khan, Javed
|
CCR (NCI)
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-21
|
$321,790
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Academic Training in Medical Oncology
|
5T32CA009297-28
|
$316,308
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
CNS vulnerability to systemic chemotherapy: Causes and prevention
|
5R01CA131385-04
|
$309,964
|
NOBLE, MARK
|
UNIVERSITY OF ROCHESTER
|
|
ATM, REACTIVE OXYGEN, AND CELLULAR RESPONSES TO HYPOXIA
|
1R01CA157216-01
|
$288,425
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
|
5R01CA122617-06
|
$258,308
|
MANNING, BRENDAN
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|